HC Wainwright Trims InflaRx (NASDAQ:IFRX) Target Price to $9

InflaRx (NASDAQ:IFRX – Get Rating) had its target price trimmed by HC Wainwright from $10.00 to $9.00 in a report released on Friday, The Fly reports. The firm currently has a buy rating on the stock. Other equities analysts have also issued research reports about the company. Lifesci Capital raised InflaRx from a market perform […]

Related Keywords

Germany , Montreal , Quebec , Canada , Renfeng Guo , Nicolas Fulpius , Niels Christoph Riedemann , Raymond James , Millennium Management , Invesco Ltd , Raymond James Financial Services Advisors Inc , Renaissance Technologies , Get Rating , Montreal Can , James Financial Services Advisors , Inflarx Daily , Inflarx , Nasdaq Ifrx , Ifrx , Medical , Lower Price Target , Hc Wainwright ,